1. Glycoengineering of NK Cells with Glycan Ligands of CD22 and Selectins for B‐Cell Lymphoma Therapy. (14th December 2020) Authors: Hong, Senlian; Yu, Chenhua; Wang, Peng; Shi, Yujie; Cao, Weiqian; Cheng, Bo; Chapla, Digantkumar G.; Ma, Yuanhui; Li, Jie; Rodrigues, Emily; Narimatsu, Yoshiki; Yates, John R.; Chen, Xing; Clausen, Henrik; Moremen, Kelly W.; Macauley, Matthew Scott; Paulson, James C.; Wu, Peng Journal: Angewandte Chemie Issue: Volume 133:Number 7(2021) Page Start: 3647 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Glycoengineering of NK Cells with Glycan Ligands of CD22 and Selectins for B‐Cell Lymphoma Therapy. Issue 7 (14th December 2020) Authors: Hong, Senlian; Yu, Chenhua; Wang, Peng; Shi, Yujie; Cao, Weiqian; Cheng, Bo; Chapla, Digantkumar G.; Ma, Yuanhui; Li, Jie; Rodrigues, Emily; Narimatsu, Yoshiki; Yates, John R.; Chen, Xing; Clausen, Henrik; Moremen, Kelly W.; Macauley, Matthew Scott; Paulson, James C.; Wu, Peng Journal: Angewandte Chemie international edition Issue: Volume 60:Issue 7(2021) Page Start: 3603 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗